Kimberly-Clark Announces Year-End 2015 Results And 2016 Outlook
Executive Summary
- Fourth quarter 2015 net sales of
$4.5 billion decreased 6 percent compared to the year-ago period, as changes in foreign currency exchange rates reduced sales 11 percent. Organic sales rose 5 percent, including a 9 percent increase in developing and emerging markets. - Diluted net income per share for the fourth quarter was income of
$0.91 in 2015 and a loss of$0.22 in 2014. Full-year diluted net income per share was$2.77 in 2015 and$4.04 in 2014. - Fourth quarter adjusted earnings per share were
$1.42 in 2015 compared to adjusted earnings per share from continuing operations of$1.35 in 2014. Performance benefited from organic sales growth, cost savings, input cost deflation and a lower share count. Comparisons were negatively impacted by unfavorable foreign currency exchange rate effects, increased marketing, research and general spending on a local currency basis and higher other expense. Adjusted earnings per share in both years exclude certain items described later in this news release. - Full-year adjusted earnings per share were
$5.76 in 2015, up 5 percent compared to adjusted earnings per share from continuing operations of$5.51 in 2014. The company's previous guidance was for adjusted earnings per share of$5.70 to$5.80 . The company's original outlook inJanuary 2015 was for adjusted earnings per share of$5.60 to$5.80 . - At the end of 2015,
Kimberly-Clark deconsolidated its Venezuelan business from the company's balance sheet and moved to the cost method of accounting for its operations inVenezuela . As a result, the company recorded an after tax charge of$102 million in the fourth quarter of 2015. - Adjusted earnings per share in 2016 are expected to be
$5.95 to$6.15 . The outlook reflects expectations for 3 to 5 percent organic sales growth, substantial cost savings, relatively benign commodity costs and significantly unfavorable foreign currency exchange rates.
Chairman and Chief Executive Officer
Falk added, "Looking to 2016, we will continue to focus on the fundamentals that create shareholder value and we expect to deliver good underlying financial performance. We will also continue to invest in our brands, our targeted growth initiatives and our capabilities. We plan to achieve healthy organic sales growth and cost savings, improve cash flow and allocate capital in shareholder-friendly ways. Despite another year of significantly unfavorable currencies, we also expect to further improve our margins and deliver 3 to 7 percent growth in adjusted earnings per share. We are very optimistic about our future and our ability to generate attractive returns to shareholders through successful execution of our Global Business Plan."
Fourth Quarter 2015 Operating Results
Sales of
Fourth quarter operating profit was
The year-over-year adjusted operating profit comparison benefited from organic sales growth,
The fourth quarter adjusted effective tax rate, which excludes the effects of the previously mentioned items excluded from adjusted earnings per share, was 30.6 percent in 2015 and 30.5 percent in 2014. The adjusted effective tax rate in the fourth quarter of 2015 also excludes the impact of a
Cash Flow and Balance Sheet
Cash provided by operations in the fourth quarter of 2015 was
Capital spending for the fourth quarter was $258 million in 2015 and $309 million in 2014. Full-year spending was
Fourth Quarter 2015 Business Segment Results
Personal Care Segment
Fourth quarter sales of
Sales in
Sales in developing and emerging markets decreased nearly 12 percent, including a negative impact from changes in currency rates of more than 23 percent. Volumes increased 6 percent and the combined impact of higher net selling prices and changes in product mix improved sales 6 percent. The volume growth included gains in
Sales in developed markets outside
Consumer Tissue Segment
Fourth quarter sales of
Sales in
Sales in developing and emerging markets decreased 23 percent, including a 26 point negative impact from currency rates. Net selling prices rose 4 percent.
Sales in developed markets outside
K-C Professional (KCP) Segment
Fourth quarter sales of
Sales in
Sales in developing and emerging markets decreased 19 percent, including a 21 point drag from currency rates. Net selling prices rose 4 percent, driven by increases in
Sales in developed markets outside
Full Year 2015 Results
Sales of
Operating profit was
Diluted net income per share was
Venezuela Update
At the end of 2015,
2014 Organization Restructuring
In
The restructuring is expected to be completed by the end of 2016, with total costs anticipated to be toward the middle of the previously communicated range of
2016 Outlook and Key Planning Assumptions
The company's key planning and guidance assumptions for 2016 are as follows:
- Net sales in a range of down 3 percent to even with the prior year.
- Organic sales growth of 3 to 5 percent, with volumes up 2 to 3 percent and changes in net selling prices and product mix, combined, up an additional 1 to 2 percent.
- Negative foreign currency exchange rate impact of 5 to 6 percent.
- Adjusted operating profit growth of 2 to 5 percent.
- Cost savings of at least
$350 million from the company's FORCE program. - Savings of at least
$50 million from the 2014 Organization Restructuring. - Negative foreign currency translation effects of 5 to 6 percent. Currency transaction effects are also anticipated to negatively impact comparisons.
- Impact of changes in key cost inputs expected to be between
$100 million of deflation and$50 million of inflation. The company is assuming North American market prices of$840 to$870 per metric ton for eucalyptus pulp and$35 to$45 per barrel for oil. Despite lower oil prices, some oil-based costs are expected to increase due to market-specific dynamics. Costs for materials in some international markets are also expected to increase due to local inflation. - Advertising spending as a percent of net sales is expected to be similar to, or up slightly, compared to 2015.
- Other (income) and expense, net is anticipated to be less expense than in 2015.
- Cost savings of at least
- Net income from equity companies similar to or up somewhat compared to 2015's level.
- Adjusted effective tax rate between 30.5 and 32.5 percent. The quarterly adjusted effective tax rate in 2016 could vary more than in 2015.
- Adjusted earnings per share of
$5.95 to$6.15 , up 3 to 7 percent versus$5.76 in 2015. - Capital spending of
$950 to$1,050 million . - Defined benefit pension plan contributions of up to
$100 million . - Dividend expected to increase mid-single digits, subject to approval by the Board of Directors. The anticipated increase is generally consistent with the 2015 growth in adjusted earnings per share from continuing operations of 5 percent.
- Share repurchases are expected to total
$600 to$900 million , subject to market conditions.
Non-GAAP Financial Measures
This press release and the accompanying tables include the following financial measures that have not been calculated in accordance with accounting principles generally accepted in the
- Adjusted earnings and earnings per share (including continuing operations)
- Adjusted gross and operating profit
- Adjusted other (income) and expense, net
- Adjusted effective tax rate
These non-GAAP financial measures exclude the following items for the relevant time periods as indicated in the accompanying non-GAAP reconciliations to the comparable GAAP financial measures:
- Deconsolidation of Venezuelan business. See previous discussion in this news release.
- Venezuelan balance sheet remeasurements. In the fourth quarter of 2014, the company recorded a charge for remeasuring the local currency balance sheet in
Venezuela at the SICAD II exchange rate. In the first quarter of 2015, following the Venezuelan government's elimination of the SICAD II exchange rate, the company recorded a charge for remeasuring the local currency balance sheet inVenezuela at the new SIMADI floating exchange rate. - Pension settlement charges. In 2015, the company started to offer a lump-sum pension benefit payout option for certain plan participants. In addition,
Kimberly-Clark purchased group annuity contracts that transferred to two insurance companies the pension benefit obligations for certainKimberly-Clark retirees. As a result, the company recognized pension settlement charges in 2015, mostly in the second quarter. - Uncertain tax positions. In the fourth quarter of 2015, the company recognized a charge, related to prior years, as a result of an updated assessment of uncertain tax positions for certain international operations.
- 2014 Organization Restructuring. See previous discussion in this news release.
Turkey restructuring. In the third quarter of 2015, the company initiated actions to restructure its business inTurkey , including the closing of a manufacturing facility. The company incurred after tax charges in the third and fourth quarters of 2015 for this restructuring. The company acquired the remaining 49.9 percent interest in its subsidiary inTurkey in conjunction with the acquisition of the remaining 49.9 percent interest in its subsidiary inIsrael in the first quarter of 2015.- Regulatory dispute in the
Middle East . In the first quarter of 2014, the company recorded a non-deductible charge as a result of an adverse court ruling regarding the treatment of capital contributions in prior years to an affiliate in theMiddle East . In the fourth quarter of 2014, the company recorded a modest amount of income as a result of an updated assessment of the liability related to the dispute. - Western and
Central Europe strategic changes and related restructuring charges. InOctober 2012 , the company initiated strategic changes and a related restructuring in its Western and Central European businesses. The restructuring was completed at the end of 2014.
In addition, this press release includes information regarding organic sales, which exclude the impact of changes in foreign currency rates.
The company provides these non-GAAP financial measures as supplemental information to our GAAP financial measures. Management and the company's Board of Directors use adjusted earnings, adjusted earnings per share and adjusted gross and operating profit to (a) evaluate the company's historical and prospective financial performance and its performance relative to its competitors, (b) allocate resources and (c) measure the operational performance of the company's business units and their managers. Management also believes that the use of an adjusted effective tax rate provides improved insight into the tax effects of our ongoing business operations.
Additionally, the
Conference Call
A conference call to discuss this news release and other matters of interest to investors and analysts will be held at
About
Copies of
Certain matters contained in this news release concerning the outlook, anticipated financial and operating results, raw material, energy and other input costs, anticipated currency rates and exchange risks, net income from equity companies, sources and uses of cash, the effective tax rate, the anticipated costs, scope, timing and financial and other effects of the 2014 Organization Restructuring, the anticipated cost savings from the company's FORCE program, growth initiatives, contingencies and anticipated transactions of the company constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events impacting the company. There can be no assurance that these future events will occur as anticipated or that the company's results will be as estimated. Forward-looking statements speak only as of the date they were made, and we
undertake no obligation to publicly update them. For a description of certain factors, such as currency rates and exchange risks, cost savings and reductions, raw material, energy and other input costs, competition, market demand and economic and political conditions, that could cause the company's future results to differ from those expressed in any such forward-looking statements, see Item 1A of the company's Annual Report on Form 10-K for the year ended
|
| ||||||||||
|
CONSOLIDATED INCOME STATEMENT | ||||||||||
|
(Millions, except per share amounts) | ||||||||||
|
Three Months Ended |
||||||||||
|
2015 |
2014 |
Change | ||||||||
|
|
$ |
4,539 |
$ |
4,828 |
-6.0 |
% | ||||
|
Cost of products sold |
2,913 |
3,275 |
-11.1 |
% | ||||||
|
Gross Profit |
1,626 |
1,553 |
+4.7 |
% | ||||||
|
Marketing, research and general expenses |
857 |
971 |
-11.7 |
% | ||||||
|
Other (income) and expense, net |
139 |
424 |
-67.2 |
% | ||||||
|
Operating Profit |
630 |
158 |
+298.7 |
% | ||||||
|
Interest income |
5 |
5 |
— |
|||||||
|
Interest expense |
(76) |
(69) |
+10.1 |
% | ||||||
|
Income From Continuing Operations Before Income Taxes and Equity Interests |
559 |
94 |
+494.7 |
% | ||||||
|
Provision for income taxes |
(252) |
(175) |
+44.0 |
% | ||||||
|
Income (Loss) From Continuing Operations Before Equity Interests |
307 |
(81) |
N.M. |
|||||||
|
Share of net income of equity companies |
37 |
33 |
+12.1 |
% | ||||||
|
Income (Loss) From Continuing Operations |
344 |
(48) |
N.M. |
|||||||
|
Income (loss) from discontinued operations, net of income taxes |
— |
(15) |
N.M. |
|||||||
|
Net Income (Loss) |
344 |
(63) |
N.M. |
|||||||
|
Net income attributable to noncontrolling interests in continuing operations |
(11) |
(20) |
-45.0 |
% | ||||||
|
Net Income (Loss) Attributable to |
$ |
333 |
$ |
(83) |
N.M. |
|||||
|
Per Share Basis |
||||||||||
|
Net Income (Loss) Attributable to |
||||||||||
|
Basic |
||||||||||
|
Continuing operations |
$ |
0.92 |
$ |
(0.18) |
N.M. |
|||||
|
Discontinued operations |
— |
(0.04) |
N.M. |
|||||||
|
Net income (loss) |
$ |
0.92 |
$ |
(0.22) |
N.M. |
|||||
|
Diluted |
||||||||||
|
Continuing operations |
$ |
0.91 |
$ |
(0.18) |
N.M. |
|||||
|
Discontinued operations |
— |
(0.04) |
N.M. |
|||||||
|
Net income (loss) |
$ |
0.91 |
$ |
(0.22) |
N.M. |
|||||
|
Cash Dividends Declared |
$ |
0.88 |
$ |
0.84 |
+4.8 |
% | ||||
|
Common Shares Outstanding |
|
|||||||||
|
2015 |
2014 |
|||||||||
|
Outstanding shares as of |
360.9 |
365.3 |
||||||||
|
Average diluted shares for three months ended |
364.5 |
373.0 |
||||||||
|
N.M. - Not Meaningful |
|
Unaudited |
|
| ||||||||||
|
CONSOLIDATED INCOME STATEMENT | ||||||||||
|
(Millions, except per share amounts) | ||||||||||
|
Twelve Months Ended |
||||||||||
|
2015 |
2014 |
Change | ||||||||
|
|
$ |
18,591 |
$ |
19,724 |
-5.7 |
% | ||||
|
Cost of products sold |
11,967 |
13,041 |
-8.2 |
% | ||||||
|
Gross Profit |
6,624 |
6,683 |
-0.9 |
% | ||||||
|
Marketing, research and general expenses |
3,443 |
3,709 |
-7.2 |
% | ||||||
|
Other (income) and expense, net |
1,568 |
453 |
+246.1 |
% | ||||||
|
Operating Profit |
1,613 |
2,521 |
-36.0 |
% | ||||||
|
Interest income |
17 |
18 |
-5.6 |
% | ||||||
|
Interest expense |
(295) |
(284) |
+3.9 |
% | ||||||
|
Income From Continuing Operations Before Income Taxes and Equity Interests |
1,335 |
2,255 |
-40.8 |
% | ||||||
|
Provision for income taxes |
(418) |
(856) |
-51.2 |
% | ||||||
|
Income From Continuing Operations Before Equity Interests |
917 |
1,399 |
-34.5 |
% | ||||||
|
Share of net income of equity companies |
149 |
146 |
+2.1 |
% | ||||||
|
Income From Continuing Operations |
1,066 |
1,545 |
-31.0 |
% | ||||||
|
Income from discontinued operations, net of income taxes |
— |
50 |
N.M. |
|||||||
|
Net Income |
1,066 |
1,595 |
-33.2 |
% | ||||||
|
Net income attributable to noncontrolling interests in continuing operations |
(53) |
(69) |
-23.2 |
% | ||||||
|
Net Income Attributable to |
$ |
1,013 |
$ |
1,526 |
-33.6 |
% | ||||
|
Per Share Basis |
||||||||||
|
Net Income Attributable to |
||||||||||
|
Basic |
||||||||||
|
Continuing operations |
$ |
2.78 |
$ |
3.94 |
-29.4 |
% | ||||
|
Discontinued operations |
— |
0.13 |
N.M. |
|||||||
|
Net income |
$ |
2.78 |
$ |
4.07 |
-31.7 |
% | ||||
|
Diluted |
||||||||||
|
Continuing operations |
$ |
2.77 |
$ |
3.91 |
-29.2 |
% | ||||
|
Discontinued operations |
— |
0.13 |
N.M. |
|||||||
|
Net income |
$ |
2.77 |
$ |
4.04 |
-31.4 |
% | ||||
|
Cash Dividends Declared |
$ |
3.52 |
$ |
3.36 |
+4.8 |
% | ||||
|
Common Shares Outstanding |
|
|||||||||
|
2015 |
2014 |
|||||||||
|
Average diluted shares for twelve months ended |
366.3 |
377.4 |
||||||||
|
N.M. - Not Meaningful |
|
2015 Data is Unaudited |
|
| |||||||||||||||||||||||||||||
|
NON-GAAP RECONCILIATIONS | |||||||||||||||||||||||||||||
|
(Millions, except per share amounts) | |||||||||||||||||||||||||||||
|
Three Months Ended | |||||||||||||||||||||||||||||
|
As Reported |
Charges Related to Venezuelan Operations |
Uncertain Tax Positions Adjustment |
Charges for Pension Settlements |
Charges for 2014 Organization Restructuring |
Charges for Turkey Restructuring |
As Adjusted Non-GAAP | |||||||||||||||||||||||
|
Cost of products sold |
$ |
2,913 |
$ |
— |
$ |
— |
$ |
— |
$ |
4 |
$ |
6 |
$ |
2,903 |
|||||||||||||||
|
Gross profit |
1,626 |
— |
— |
— |
(4) |
(6) |
1,636 |
||||||||||||||||||||||
|
Marketing, research and general expenses |
857 |
— |
— |
— |
23 |
— |
834 |
||||||||||||||||||||||
|
Other (income) and expense, net |
139 |
108 |
— |
8 |
— |
— |
23 |
||||||||||||||||||||||
|
Operating profit |
630 |
(108) |
— |
(8) |
(27) |
(6) |
779 |
||||||||||||||||||||||
|
Income from continuing operations before income taxes and equity interests |
559 |
(108) |
— |
(8) |
(27) |
(6) |
708 |
||||||||||||||||||||||
|
Provision for income taxes |
(252) |
6 |
(49) |
3 |
5 |
— |
(217) |
||||||||||||||||||||||
|
Effective tax rate |
45.1 |
% |
— |
— |
— |
— |
— |
30.6 |
% | ||||||||||||||||||||
|
Net income attributable to |
333 |
(102) |
(49) |
(5) |
(22) |
(6) |
517 |
||||||||||||||||||||||
|
Diluted earnings per share(a) |
0.91 |
(0.28) |
(0.13) |
(0.01) |
(0.06) |
(0.02) |
1.42 |
||||||||||||||||||||||
|
(a) |
"As Adjusted Non-GAAP" does not equal "As Reported" plus "Charges" as a result of rounding. |
||||||||||||||||||||||||||||
|
Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP. There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. The company compensates for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures. |
|
Unaudited |
|
| ||||||||||||||||||||||||||||
|
NON-GAAP RECONCILIATIONS | ||||||||||||||||||||||||||||
|
(Millions, except per share amounts) | ||||||||||||||||||||||||||||
|
Three Months Ended | ||||||||||||||||||||||||||||
|
As Reported |
Charges for European Strategic Changes |
Charges Related to Health Care Spin-off |
Regulatory Dispute in |
Charges for 2014 Organization Restructuring |
Charges Related to Venezuelan Operations |
As Adjusted Non-GAAP | ||||||||||||||||||||||
|
Cost of products sold |
$ |
3,275 |
$ |
2 |
$ |
— |
$ |
— |
$ |
40 |
$ |
41 |
$ |
3,192 |
||||||||||||||
|
Gross profit |
1,553 |
(2) |
— |
— |
(40) |
(41) |
1,636 |
|||||||||||||||||||||
|
Marketing, research and general expenses |
971 |
18 |
— |
— |
93 |
— |
860 |
|||||||||||||||||||||
|
Other (income) and expense, net |
424 |
— |
— |
(4) |
— |
421 |
7 |
|||||||||||||||||||||
|
Operating profit |
158 |
(20) |
— |
4 |
(133) |
(462) |
769 |
|||||||||||||||||||||
|
Income from continuing operations before income taxes and equity interests |
94 |
(20) |
— |
4 |
(133) |
(462) |
705 |
|||||||||||||||||||||
|
Provision for income taxes |
(175) |
2 |
— |
— |
38 |
— |
(215) |
|||||||||||||||||||||
|
Effective tax rate |
186.2 |
% |
— |
— |
— |
— |
— |
30.5 |
% | |||||||||||||||||||
|
Income (loss) from continuing operations |
(48) |
(18) |
— |
4 |
(95) |
(462) |
523 |
|||||||||||||||||||||
|
Net income attributable to noncontrolling interests in continuing operations |
(20) |
— |
— |
(2) |
— |
— |
(18) |
|||||||||||||||||||||
|
Income (loss) from continuing operations attributable to |
(68) |
(18) |
— |
2 |
(95) |
(462) |
505 |
|||||||||||||||||||||
|
Diluted earnings (loss) per share from continuing operations |
(0.18) |
(0.05) |
— |
0.01 |
(0.25) |
(1.24) |
1.35 |
|||||||||||||||||||||
|
Income (loss) from discontinued operations, net of income taxes |
(15) |
— |
(44) |
— |
— |
— |
29 |
|||||||||||||||||||||
|
Diluted earnings (loss) per share from discontinued operations |
(0.04) |
— |
(0.12) |
— |
— |
— |
0.08 |
|||||||||||||||||||||
|
Net income (loss) attributable to |
(83) |
(18) |
(44) |
2 |
(95) |
(462) |
534 |
|||||||||||||||||||||
|
Diluted earnings (loss) per share |
(0.22) |
(0.05) |
(0.12) |
0.01 |
(0.25) |
(1.24) |
1.43 |
|||||||||||||||||||||
|
Unaudited |
|
| |||||||||||||||||||||||||||||
|
NON-GAAP RECONCILIATIONS | |||||||||||||||||||||||||||||
|
(Millions, except per share amounts) | |||||||||||||||||||||||||||||
|
Twelve Months Ended | |||||||||||||||||||||||||||||
|
As Reported |
Charges Related to Venezuelan Operations |
Uncertain Tax Positions Adjustment |
Charges for Pension Settlements |
Charges for 2014 Organization Restructuring |
Charges for Turkey Restructuring |
As Adjusted Non-GAAP | |||||||||||||||||||||||
|
Cost of products sold |
$ |
11,967 |
$ |
5 |
$ |
— |
$ |
— |
$ |
23 |
$ |
22 |
$ |
11,917 |
|||||||||||||||
|
Gross profit |
6,624 |
(5) |
— |
— |
(23) |
(22) |
6,674 |
||||||||||||||||||||||
|
Marketing, research and general expenses |
3,443 |
— |
— |
— |
40 |
1 |
3,402 |
||||||||||||||||||||||
|
Other (income) and expense, net |
1,568 |
148 |
— |
1,358 |
— |
— |
62 |
||||||||||||||||||||||
|
Operating profit |
1,613 |
(153) |
— |
(1,358) |
(63) |
(23) |
3,210 |
||||||||||||||||||||||
|
Income from continuing operations before income taxes and equity interests |
1,335 |
(153) |
— |
(1,358) |
(63) |
(23) |
2,932 |
||||||||||||||||||||||
|
Provision for income taxes |
(418) |
6 |
(49) |
523 |
21 |
— |
(919) |
||||||||||||||||||||||
|
Effective tax rate |
31.3 |
% |
— |
— |
— |
— |
— |
31.3 |
% | ||||||||||||||||||||
|
Net income attributable to |
1,013 |
(147) |
(49) |
(835) |
(42) |
(23) |
2,109 |
||||||||||||||||||||||
|
Diluted earnings per share(a) |
2.77 |
(0.40) |
(0.13) |
(2.28) |
(0.11) |
(0.06) |
5.76 |
||||||||||||||||||||||
|
(a) |
"As Adjusted Non-GAAP" does not equal "As Reported" plus "Charges" as a result of rounding. |
||||||||||||||||||||||||||||
|
Unaudited |
|
| ||||||||||||||||||||||||||||
|
NON-GAAP RECONCILIATIONS | ||||||||||||||||||||||||||||
|
(Millions, except per share amounts) | ||||||||||||||||||||||||||||
|
Twelve Months Ended | ||||||||||||||||||||||||||||
|
As Reported |
Charges for European Strategic Changes |
Charges Related to Health Care Spin-off |
Charge Related to Regulatory Dispute in |
Charges for 2014 Organization Restructuring |
Charges Related to Venezuelan Operations |
As Adjusted Non-GAAP | ||||||||||||||||||||||
|
Cost of products sold |
$ |
13,041 |
$ |
11 |
$ |
— |
$ |
— |
$ |
40 |
$ |
41 |
$ |
12,949 |
||||||||||||||
|
Gross profit |
6,683 |
(11) |
— |
— |
(40) |
(41) |
6,775 |
|||||||||||||||||||||
|
Marketing, research and general expenses |
3,709 |
22 |
— |
— |
93 |
— |
3,594 |
|||||||||||||||||||||
|
Other (income) and expense, net |
453 |
— |
— |
35 |
— |
421 |
(3) |
|||||||||||||||||||||
|
Operating profit |
2,521 |
(33) |
— |
(35) |
(133) |
(462) |
3,184 |
|||||||||||||||||||||
|
Income from continuing operations before income taxes and equity interests |
2,255 |
(33) |
— |
(35) |
(133) |
(462) |
2,918 |
|||||||||||||||||||||
|
Provision for income taxes |
(856) |
3 |
— |
— |
38 |
— |
(897) |
|||||||||||||||||||||
|
Effective tax rate |
38.0 |
% |
— |
— |
— |
— |
— |
30.7 |
% | |||||||||||||||||||
|
Income from continuing operations |
1,545 |
(30) |
— |
(35) |
(95) |
(462) |
2,167 |
|||||||||||||||||||||
|
Net income attributable to noncontrolling interests in continuing operations |
(69) |
— |
— |
18 |
— |
— |
(87) |
|||||||||||||||||||||
|
Income from continuing operations attributable to |
1,476 |
(30) |
— |
(17) |
(95) |
(462) |
2,080 |
|||||||||||||||||||||
|
Diluted earnings per share from continuing operations |
3.91 |
(0.08) |
— |
(0.05) |
(0.25) |
(1.22) |
5.51 |
|||||||||||||||||||||
|
Income from discontinued operations, net of income taxes |
50 |
— |
(138) |
— |
— |
— |
188 |
|||||||||||||||||||||
|
Diluted earnings per share from discontinued operations |
0.13 |
— |
(0.37) |
— |
— |
— |
0.50 |
|||||||||||||||||||||
|
Net income attributable to |
1,526 |
(30) |
(138) |
(17) |
(95) |
(462) |
2,268 |
|||||||||||||||||||||
|
Diluted earnings per share |
4.04 |
(0.08) |
(0.37) |
(0.05) |
(0.25) |
(1.22) |
6.01 |
|||||||||||||||||||||
|
Unaudited |
|
| |||||||
|
CONSOLIDATED BALANCE SHEET | |||||||
|
(Millions) | |||||||
|
| |||||||
|
2015 |
2014 | ||||||
|
ASSETS |
|||||||
|
Current Assets |
|||||||
|
Cash and cash equivalents |
$ |
619 |
$ |
789 |
|||
|
Accounts receivable, net |
2,281 |
2,223 |
|||||
|
Inventories |
1,909 |
1,892 |
|||||
|
Other current assets |
617 |
655 |
|||||
|
Total Current Assets |
5,426 |
5,559 |
|||||
|
Property, Plant and Equipment, Net |
7,104 |
7,359 |
|||||
|
Investments in Equity Companies |
247 |
257 |
|||||
|
|
1,446 |
1,628 |
|||||
|
Other Assets |
619 |
723 |
|||||
|
TOTAL ASSETS |
$ |
14,842 |
$ |
15,526 |
|||
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||
|
Current Liabilities |
|||||||
|
Debt payable within one year |
$ |
1,669 |
$ |
1,326 |
|||
|
Trade accounts payable |
2,612 |
2,616 |
|||||
|
Accrued expenses |
1,750 |
1,974 |
|||||
|
Dividends payable |
318 |
310 |
|||||
|
Total Current Liabilities |
6,349 |
6,226 |
|||||
|
Long-Term Debt |
6,106 |
5,630 |
|||||
|
Noncurrent Employee Benefits |
1,137 |
1,693 |
|||||
|
Deferred Income Taxes |
766 |
587 |
|||||
|
Other Liabilities |
380 |
319 |
|||||
|
Redeemable Preferred Securities of Subsidiaries |
64 |
72 |
|||||
|
Stockholders' Equity (Deficit) |
|||||||
|
|
(174) |
729 |
|||||
|
Noncontrolling Interests |
214 |
270 |
|||||
|
Total Stockholders' Equity |
40 |
999 |
|||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
$ |
14,842 |
$ |
15,526 |
|||
|
2015 Data is Unaudited |
|
| |||||||||||||||
|
CONSOLIDATED CASH FLOW STATEMENT | |||||||||||||||
|
(Millions) | |||||||||||||||
|
Three Months Ended |
Twelve Months Ended | ||||||||||||||
|
2015 |
2014 |
2015 |
2014 | ||||||||||||
|
Operating Activities |
|||||||||||||||
|
Net income (loss) |
$ |
344 |
$ |
(63) |
$ |
1,066 |
$ |
1,595 |
|||||||
|
Depreciation and amortization |
181 |
207 |
746 |
862 |
|||||||||||
|
Asset impairments |
2 |
— |
22 |
42 |
|||||||||||
|
Stock-based compensation |
7 |
1 |
75 |
52 |
|||||||||||
|
Deferred income taxes |
123 |
6 |
(255) |
63 |
|||||||||||
|
Net (gains) losses on asset dispositions |
12 |
32 |
17 |
21 |
|||||||||||
|
Equity companies' earnings (in excess of) less than dividends paid |
28 |
55 |
(10) |
28 |
|||||||||||
|
(Increase) decrease in operating working capital |
(129) |
(113) |
(445) |
(176) |
|||||||||||
|
Postretirement benefits |
(11) |
17 |
930 |
(102) |
|||||||||||
|
Charges related to Venezuelan Operations |
108 |
462 |
153 |
462 |
|||||||||||
|
Other |
— |
(14) |
7 |
(2) |
|||||||||||
|
Cash Provided by Operations |
665 |
590 |
2,306 |
2,845 |
|||||||||||
|
Investing Activities |
|||||||||||||||
|
Capital spending |
(258) |
(309) |
(1,056) |
(1,039) |
|||||||||||
|
Proceeds from dispositions of property |
1 |
2 |
27 |
38 |
|||||||||||
|
Proceeds from sales of investments |
— |
31 |
— |
127 |
|||||||||||
|
Investments in time deposits |
(46) |
(28) |
(146) |
(151) |
|||||||||||
|
Maturities of time deposits |
64 |
48 |
164 |
239 |
|||||||||||
|
Other |
12 |
11 |
(39) |
16 |
|||||||||||
|
Cash Used for Investing |
(227) |
(245) |
(1,050) |
(770) |
|||||||||||
|
Financing Activities |
|||||||||||||||
|
Cash dividends paid |
(320) |
(314) |
(1,272) |
(1,256) |
|||||||||||
|
Change in short-term debt |
412 |
568 |
303 |
721 |
|||||||||||
|
Debt proceeds |
3 |
636 |
1,100 |
1,257 |
|||||||||||
|
Debt repayments |
(204) |
(14) |
(553) |
(123) |
|||||||||||
|
Redemption of redeemable preferred securities of subsidiary |
— |
(500) |
— |
(500) |
|||||||||||
|
Cash paid on redeemable preferred securities of subsidiaries |
(2) |
(12) |
(3) |
(34) |
|||||||||||
|
Proceeds from exercise of stock options |
38 |
29 |
140 |
127 |
|||||||||||
|
Acquisitions of common stock for the treasury |
(358) |
(817) |
(861) |
(1,939) |
|||||||||||
|
Cash transferred to Halyard Health, Inc. related to spin-off |
— |
(120) |
— |
(120) |
|||||||||||
|
Shares purchased from noncontrolling interest |
— |
— |
(151) |
— |
|||||||||||
|
Other |
(8) |
(26) |
(1) |
(26) |
|||||||||||
|
Cash Used for Financing |
(439) |
(570) |
(1,298) |
(1,893) |
|||||||||||
|
Effect of Exchange Rate Changes on Cash and Cash Equivalents |
(23) |
(417) |
(128) |
(447) |
|||||||||||
|
Increase (Decrease) in Cash and Cash Equivalents |
(24) |
(642) |
(170) |
(265) |
|||||||||||
|
Cash and Cash Equivalents - Beginning of Period |
643 |
1,431 |
789 |
1,054 |
|||||||||||
|
Cash and Cash Equivalents - End of Period |
$ |
619 |
$ |
789 |
$ |
619 |
$ |
789 |
|||||||
|
Unaudited |
|
| ||||||||||||||||||||||
|
SELECTED BUSINESS SEGMENT DATA | ||||||||||||||||||||||
|
(Millions) | ||||||||||||||||||||||
|
Three Months Ended |
Twelve Months Ended |
|||||||||||||||||||||
|
2015 |
2014 |
Change |
2015 |
2014 |
Change | |||||||||||||||||
|
|
||||||||||||||||||||||
|
Personal Care |
$ |
2,233 |
$ |
2,336 |
-4.4 |
% |
$ |
9,204 |
$ |
9,635 |
-4.5 |
% | ||||||||||
|
Consumer Tissue |
1,520 |
1,621 |
-6.2 |
% |
6,121 |
6,645 |
-7.9 |
% | ||||||||||||||
|
K-C Professional |
776 |
857 |
-9.5 |
% |
3,219 |
3,388 |
-5.0 |
% | ||||||||||||||
|
Corporate & Other |
10 |
14 |
N.M. |
47 |
56 |
N.M. |
||||||||||||||||
|
TOTAL |
$ |
4,539 |
$ |
4,828 |
-6.0 |
% |
$ |
18,591 |
$ |
19,724 |
-5.7 |
% | ||||||||||
|
OPERATING PROFIT |
||||||||||||||||||||||
|
Personal Care |
$ |
473 |
$ |
410 |
+15.4 |
% |
$ |
1,885 |
$ |
1,803 |
+4.5 |
% | ||||||||||
|
Consumer Tissue |
262 |
280 |
-6.4 |
% |
1,073 |
1,062 |
+1.0 |
% | ||||||||||||||
|
K-C Professional |
157 |
151 |
+4.0 |
% |
590 |
604 |
-2.3 |
% | ||||||||||||||
|
Corporate & Other(a) |
(123) |
(259) |
N.M. |
(367) |
(495) |
N.M. |
||||||||||||||||
|
Other (income) and expense, |
139 |
424 |
-67.2 |
% |
1,568 |
453 |
+246.1 |
% | ||||||||||||||
|
TOTAL OPERATING PROFIT |
$ |
630 |
$ |
158 |
+298.7 |
% |
$ |
1,613 |
$ |
2,521 |
-36.0 |
% | ||||||||||
|
(a) |
Segment Operating Profit excludes other (income) and expense, net and expenses not associated with the business segments, including charges as indicated in the Non-GAAP Reconciliations. |
|
N.M. - Not Meaningful |
|
Unaudited |
|
| |||||||||||||||
|
SELECTED BUSINESS SEGMENT DATA | |||||||||||||||
|
PERCENTAGE CHANGE IN NET SALES VERSUS PRIOR YEAR | |||||||||||||||
|
Three Months Ended | |||||||||||||||
|
Total |
Volume |
Net Price |
Mix/ Other(a) |
Currency | |||||||||||
|
Personal Care |
(4.4) |
6 |
1 |
1 |
(12) |
||||||||||
|
Consumer Tissue |
(6.2) |
4 |
(1) |
— |
(9) |
||||||||||
|
K-C Professional |
(9.5) |
(2) |
2 |
— |
(9) |
||||||||||
|
TOTAL CONSOLIDATED |
(6.0) |
4 |
1 |
— |
(11) |
||||||||||
|
Twelve Months Ended | ||||||||||||||
|
Total |
Volume |
Net Price |
Mix/ Other(a) |
Currency | ||||||||||
|
Personal Care |
(4.5) |
5 |
1 |
1 |
(11) |
|||||||||
|
Consumer Tissue |
(7.9) |
3 |
(1) |
(1) |
(9) |
|||||||||
|
K-C Professional |
(5.0) |
2 |
— |
2 |
(9) |
|||||||||
|
TOTAL CONSOLIDATED |
(5.7) |
4 |
— |
— |
(10) |
|||||||||
|
(a) |
Mix/Other includes rounding. |
|
Unaudited |
|
| ||||||||||
|
OUTLOOK FOR 2016 | ||||||||||
|
| ||||||||||
|
ESTIMATED FULL YEAR 2016 DILUTED EARNINGS PER SHARE |
||||||||||
|
Adjusted earnings per share |
$ |
5.95 |
- |
$ |
6.15 |
|||||
|
Adjustment for charges related to the 2014 Organization Restructuring |
(0.06) |
- |
(0.03) |
|||||||
|
Per share basis - diluted net income attributable to |
$ |
5.89 |
- |
$ |
6.12 |
|||||
[KMB-F]
Logo - http://photos.prnewswire.com/prnh/20110928/DA76879LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kimberly-clark-announces-year-end-2015-results-and-2016-outlook-300208748.html
SOURCE
News Provided by Acquire Media